Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001962902 | SCV002236245 | pathogenic | Deficiency of hyaluronoglucosaminidase | 2023-02-09 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1454959). This variant has not been reported in the literature in individuals affected with HYAL1-related conditions. This variant is present in population databases (rs781974681, gnomAD 0.006%). This sequence change creates a premature translational stop signal (p.Asn29Thrfs*31) in the HYAL1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HYAL1 are known to be pathogenic (PMID: 10339581, 21559944). |
Fulgent Genetics, |
RCV001962902 | SCV005662609 | likely pathogenic | Deficiency of hyaluronoglucosaminidase | 2024-02-23 | criteria provided, single submitter | clinical testing |